首页|儿童非伤寒沙门菌胃肠炎抗感染治疗研究进展

儿童非伤寒沙门菌胃肠炎抗感染治疗研究进展

扫码查看
目的 为儿童非伤寒沙门菌(NTS)胃肠炎抗感染治疗提供参考。方法 采用计算机检索PubMed,Web of Science,The Cochrane Library和中国知网数据库中自建库起至2023年12月的儿童NTS胃肠炎抗感染治疗相关文献,从NTS的微生物学特点、流行病学、耐药性及抗感染治疗方案进行总结。结果 儿童是NTS感染的高危人群;在非免疫缺陷情况下,儿童NTS胃肠炎感染程度通常较轻,具有自限性,无须治疗;重度感染、新生儿和低于3月龄、先天性或医源性免疫缺陷患儿需抗感染治疗。目前,第3代头孢菌素、喹诺酮类和大环内酯类抗菌药物为主要治疗药物,具体用法用量应遵循相关指南,疗程以7~10d为宜。结论 应严格把握儿童NTS胃肠炎抗感染治疗指征,制订合理的抗感染治疗方案,以规范抗菌药物的合理使用,遏制细菌耐药。
Research Progress on Anti-Infective Treatment of Non-Typhoid Salmonella Gastroenteritis in Children
Objective To provide a reference for the anti-infective treatment of children with non-typhoidal Salmonella(NTS)gastroenteritis.Methods The literature related to anti-infective treatment of children with NTS gastroenteritis in the PubMed,Web of Science,The Cochrane Library,and CNKI were searched from the inception of these databases to December 2023.The microbiological characteristics,epidemiology,drug resistance,and anti-infective treatment plans of NTS were summarized.Results Children are at high risk of NTS infection.In the absence of immunodeficiency,NTS gastroenteritis infection in children is generally mild and self-limiting,without treatment.Anti-infective treatment were required for severe infections,newborns and infants less than three months,and children with congenital or iatrogenic immunodeficiency.At present,the third-generation cephalosporins,quinolone antibiotics and macrolides antibiotics are the main therapeutic drugs,and the specific usage and dosage should follow relevant guidelines.The recommended course of treatment is 7-10 d.Conclusion It is necessary to strictly grasp the indications of anti-infective treatment of children with NTS gastroenteritis and formulate a reasonable anti-infective treatment plan to standardize the rational use of antibiotics,and curb antimicrobial resistance.

childrennon-typhoidal Salmonellagastroenteritisanti-infectiveprogress

李高芬、李俊、邱秀燕、杨雅

展开 >

中国人民解放军陆军军医大学第二附属医院,重庆 400037

重庆医科大学附属儿童医院·国家儿童健康与疾病临床医学研究中心·儿童发育疾病研究教育部重点实验室·儿童感染与免疫罕见病重庆市重点实验室,重庆 401122

儿童 非伤寒沙门菌 胃肠炎 抗感染 进展

重庆市科卫联合医学科研项目

2024MSXM177

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(17)